← FDA Drug Approvals (Drugs@FDA)

CARMUSTINE

NDA · New Drug Application · Sponsor: ACCORD HLTHCARE · Approved 2022-05-16

Drug application

FDA Application #

NDA215000

Application type

New Drug Application

Brand name

CARMUSTINE

Generic name

Carmustine

Active ingredients

CARMUSTINE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Discontinued

Sponsor

ACCORD HLTHCARE

First approval

2022-05-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown